Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Hair microscopy is a useful and affordable way to diagnose hair disorders.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Keratin 15 is not a reliable sole marker for identifying epidermal stem cells because it's found in various cell types.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Hair transplantation between identical twins can successfully treat severe, nonprogressive hair loss due to follicular aplasia.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

The gel with hops extract effectively treats severe acne wounds by healing and reducing infection.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The document suggests more research is needed to understand skin conditions related to toothpaste and other treatments.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.